← Leaderboards
Christopher S. Sullivan
University Of Texas At Austin
$4,973,071
Attributed
$5,895,257
Total exposure
6
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.1M · FY2009–25$2M$1.5M$1M$500K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,895,257 · 6
By mechanism
R01$4,864,273 · 3
R21$1,030,984 · 3
Top collaborators
- Glenn C Randall4 shared
Most similar at University Of Texas At Austin
Same institution · by research overlap
- Andrew D Ellington$16,705,732
- Sara Sawyer$15,782,361
Others in their field
Top investigators on “Viral”
- Lawrence Corey · Fred Hutchinson Cancer Center$466,994,927
- David Heimbrook · Leidos Biomedical Research, Inc.$366,090,791
- Daniel R Kuritzkes · Brigham And Women'S Hospital$267,074,199
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$252,763,614
- Judith S. Currier · University Of California Los Angeles$185,434,785
- Constance Ann Benson · University Of California, San Diego$165,517,633
Research focus
ViralVirusCellsMolecularAntiviral AgentsProteinsTranscriptMediatingMicrornasPreventBiologyPublic HealthFutureInnovationCodeInfectionPreventionMemberBiochemicalVirus DiseasesUntranslated RnaFamilyPathway InteractionsVirus Replication
Grant awards (18)
Exploiting pseudogenetic screens to unravel small DNA virus persistence$192,889
R21 · FY2025 · AI · contact PI
Elucidating How Tri-phosphatase DUSP11 Controls HCV Infection and Hepatocyte Inflammation$449,504
R01 · FY2021 · AI · contact PI
Non-coding RNA and ADP-ribosylation in Antiviral Defense$378,820
R01 · FY2021 · AI · contact PI
Elucidating How Tri-phosphatase DUSP11 Controls HCV Infection and Hepatocyte Inflammation$454,159
R01 · FY2020 · AI · contact PI
Non-coding RNA and ADP-ribosylation in Antiviral Defense$378,820
R01 · FY2020 · AI · contact PI
Elucidating the function of a family of respiratory viral long noncoding RNAs$228,535
R21 · FY2020 · AI · contact PI
Elucidating How Tri-phosphatase DUSP11 Controls HCV Infection and Hepatocyte Inflammation$458,681
R01 · FY2019 · AI · contact PI
Non-coding RNA and ADP-ribosylation in Antiviral Defense$378,820
R01 · FY2019 · AI · contact PI
Elucidating the function of a family of respiratory viral long noncoding RNAs$189,410
R21 · FY2019 · AI · contact PI
Elucidating How Tri-phosphatase DUSP11 Controls HCV Infection and Hepatocyte Inflammation$482,028
R01 · FY2018 · AI · contact PI
Non-coding RNA and ADP-ribosylation in Antiviral Defense$378,820
R01 · FY2018 · AI · contact PI
Role of RNAi factor DUSP11 in ocular biology and disease$224,033
R21 · FY2018 · EY · contact PI
Non-coding RNA and ADP-ribosylation in Antiviral Defense$378,820
R01 · FY2017 · AI · contact PI
Role of RNAi factor DUSP11 in ocular biology and disease$196,117
R21 · FY2017 · EY · contact PI
Role of microRNAs in the SV40 infectious cycle$266,341
R01 · FY2012 · AI · contact PI
Role of microRNAs in the SV40 infectious cycle$278,794
R01 · FY2011 · AI · contact PI
Role of microRNAs in the SV40 infectious cycle$289,146
R01 · FY2010 · AI · contact PI
Role of microRNAs in the SV40 infectious cycle$291,520
R01 · FY2009 · AI · contact PI